Stockreport

Analysts Have Lowered Expectations For Vir Biotechnology, Inc. (NASDAQ:VIR) After Its Latest Results [Yahoo! Finance]

Vir Biotechnology, Inc.  (VIR) 
PDF Statutory earnings fell substantially short of expectations, with revenues of US$2.4m missing forecasts by 57%. Losses exploded, with a per-share loss of US$1.56 some 63 [Read more]